Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis

21Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Colorectal cancer is one common digestive malignancy, and the most common approach of blood metastasis of colorectal cancer is through the portal vein system to the liver. Early detection and treatment of liver metastasis is the key to improving the prognosis of the patients. Radiomics and radiogenomics use non-invasive methods to evaluate the biological properties of tumors by deeply mining the texture features of images and quantifying the heterogeneity of metastatic tumors. Radiomics and radiogenomics have been applied widely in the detection, treatment, and prognostic evaluation of colorectal cancer liver metastases. Based on the imaging features of the liver, this paper reviews the current application of radiomics and radiogenomics in the diagnosis, treatment, monitor of disease progression, and prognosis of patients with colorectal cancer liver metastases.

Cite

CITATION STYLE

APA

Wang, Y., Ma, L. Y., Yin, X. P., & Gao, B. L. (2022, January 7). Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2021.689509

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free